Top Stories
In a major relief for patients requiring expensive treatments, the Indian government has granted a full customs duty exemption on 36 life-saving medicines. These include drugs for cancer, rare diseases, and other critical health conditions. Additionally, six more medicines will now be subject to a reduced customs duty of 5%. The move is expected to lower the cost of these crucial treatments and make them more accessible to those in need.
The exemption list features key medications such as Tepotinib, which is used to treat non-small cell lung cancer, and Avelumab, a monoclonal antibody prescribed for certain cancers. Other drugs like Asciminib, which targets specific white blood cell cancers, and Alglucosidase Alfa, used for Pompe disease, have also been included. The exemption is expected to significantly reduce financial strain on patients undergoing treatment for these conditions.
Along with these exemptions, the government has expanded the number of medicines eligible for duty-free import under various Patient Assistance Programmes. A total of 37 new medicines and 13 additional assistance programs have been added to the list. This initiative is aimed at supporting patients who require high-cost treatments by improving access to essential medications at reduced or no cost.
Officials believe that this decision will not only ease the financial burden on patients and their families but also strengthen India’s healthcare infrastructure. By making critical medicines more affordable, the government aims to ensure that more people can benefit from advanced medical treatments without facing significant financial hardships.
This initiative aligns with the government’s broader vision of improving healthcare affordability and accessibility across the country. Experts have welcomed the move, emphasizing that it could lead to better health outcomes and improved survival rates for patients with serious medical conditions.
Punjab and Haryana High Court Criticizes Doctors' Illegible Handwriting
The Indian Medical Association (IMA) has voiced its dissatisfaction with what it perceives as the "cherry-picking" of Indian physicians to address the shortage of medical professionals in the UK's National Health Service (NHS), citing the lack of substantial benefits for the medical community in India.
ചെന്നൈ: രാജീവ് ഗാന്ധി സർക്കാർ ജനറൽ ആശുപത്രിയിൽ ജോലി ചെയ്യുന്ന 30 കാരനായ ഡോക്ടറെ തിങ്കളാഴ്ച ചൂളൈമേട്ടിലെ വീട്ടിൽ മരിച്ച നിലയിൽ കണ്ടെത്തി.
ബാംഗ്ലൂർ: ബെംഗളൂരുവിലെ ഒരു ആശുപത്രിയിലെ ഡോക്ടർമാർ അടുത്തിടെ 68 വയസ്സുള്ള ഒരു സ്ത്രീയിൽ നിന്ന് 7.2 സെന്റീമീറ്റർ വലിപ്പമുള്ള വൃക്കയിലെ കല്ല് നീക്കം ചെയ്തു. രക്താതിമർദ്ദം, പ്രമേഹം, പാർക്കിൻസൺസ് രോഗം, മറ്റ് ഹൃദയ സംബന്ധമായ അസുഖങ്ങൾ തുടങ്ങി വിവിധ രോഗങ്ങളാൽ ഈ സ്ത്രീ കഷ്ടപ്പെടുകയായിരുന്നു.
In a landmark achievement, doctors at the Jaslok Hospital and Research Centre in Mumbai announced the successful Total Knee Replacement (TKR) procedure on a 72-year-old American man, weighing a remarkable 193 kg. This groundbreaking surgery marks a significant milestone as the heaviest patient ever to undergo such a procedure globally. TKR stands as a transformative intervention for individuals grappling with excruciating knee pain, offering them renewed mobility and an improved quality of life. However, for overweight individuals, accessing this treatment presents formidable challenges due to heightened surgical risks and technical intricacies.
According to the surgical team, led by Dr. Rajesh Nawalkar, Senior Consultant in Orthopaedics, every patient's unique circumstances demand a tailored approach to surgery. By meticulously customizing their techniques and collaborating closely with fellow medical professionals, they successfully navigated the complexities posed by the patient's weight, culminating in a triumphant outcome. Among the foremost hurdles encountered in TKR for overweight patients are the elevated risks associated with anesthesia and the heightened potential for embolism. This underscores the importance of precision and vigilance in addressing the specific needs of each patient to ensure optimal results and minimize complications.
Furthermore, the conventional use of a tourniquet, a standard protocol in TKR surgeries, presents technical challenges due to the patient's larger thigh circumference, heightening the risk of tissue damage and post-operative complications. In response to these challenges, Dr. Nawalkar collaborated closely with instrument manufacturers to devise specialized instruments tailored to accommodate the patient's unique anatomy, thereby ensuring optimal surgical outcomes. Additionally, meticulous preoperative assessments and consultations were conducted to ascertain the patient's readiness and obtain informed consent.
Richard Koszarek, the patient, underwent the surgery on January 7, 2024, with no reported complications during the procedure. However, the path to recovery was equally crucial, with rehabilitation playing a pivotal role in achieving successful outcomes. Despite facing reluctance from numerous doctors in India and abroad due to his weight, Richard expressed gratitude to the surgical team for their unwavering commitment and skillful intervention, which enabled him to regain mobility and resume an active lifestyle.
We have various options to advertise with us including Events, Advertorials, Banners, Mailers, etc.
